AIDS-HIV

Moçambique tem de encontrar um milhão com HIV que está fora de tratamento External link

Source country visao Wednesday, April 21, 2021 1:25:00 PM CEST | info English text... [en] [other]

Trigger words: [AIDS-HIV] HIV[7]; SIDA[1];

Entities: Winnie Byanyima[3]; Filipe Nyusi[1];

Other categories:

Moçambique tem de encontrar um milhão de pessoas com HIV que estão fora do tratamento antirretroviral no país, levá-las a entrar na terapia e a permanecer nela, disse hoje a sub-secretária Geral das Nações Unidas, Winnie Byanyima. “Hoje há 2,2 milhões de pessoas que são positivas para o HIV [em.......

Mozambique needs to find one-million-signature out-of-pack unshakeably with HIV treatment

Mozambique must find a million people with HIV who are outside the antirretroviral treatment in the country they are entering the therapy and to remain in it, said today the sub-secretária United Nations general Winnie Byanyima. “Today there are 2.2 million people who are positive for HIV [in....

13:53 Lauksaimniecība pārmaiņu priekšvakarā External link

Source country Db Wednesday, April 21, 2021 1:24:00 PM CEST | info English text... [en] [other]

Trigger words: [AIDS-HIV] cilvēka[2];

Other categories: Coronavirus Infection;

Ne tikai Latvijā, bet visā Eiropas Savienībā lauksaimniecība atrodas lielu pārmaiņu priekšvakarā, par to ieviešanas ātrumu gan vēl pāragri runāt, jo visos līmeņos turpinās diskusijas. Intervijā Dienas Biznesam zemkopības ministrs Kaspars Gerhards norāda, ka Eiropas Savienība ir izvirzījusi ļoti.......

13:53 on the eve of the change agriculture

Not only in Latvia, but also throughout the EUropean union great change agriculture is well on the eve of the speed of implementation of the the and inefficiencies both speak because at all levels continue its discussions. The minister for agriculture business days interview Kaspars Gerhards point out that the EUropean union has made very....

More articles...

Hepatitis B

Antios Therapeutics Doses First Patients in SAVE 1, a Phase 2a Study of ATI-2173 in Patients with Chronic Hepatitis B Virus (HBV) External link

Source country 4-traders Wednesday, April 21, 2021 1:31:00 PM CEST | info [other]

Trigger words: [HepatitisB] Hepatitis B Virus[1]; hepatitis B[2]; HBV[14]; Hepatitis B[1];

Other categories: Antiviral;

SAVE 1 to evaluate ATI-2173 in combination with tenofovir (TDF) vs. TDF plus placebo SAVE 1 to include cohort of Hepatitis Delta Virus (HDV) co-infected subjects to assess ATI-2173 activity against HDV. MENDHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc....

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines i External link

Source country cambridge Wednesday, April 21, 2021 11:45:00 AM CEST | info [other]

Study design and participants. This was a phase III, open-label, randomised, active-controlled, multi-centre study in healthy meningococcal vaccine-naïve toddlers aged 12–23 months to evaluate the immunogenicity and safety of MenACYW-TT when coadministered with routinely used paediatric vaccines in.......

More articles...

Hepatitis C

Covid, tre nuovi antivirali in arrivo mentre continua lo studio sugli... External link

Source country gazzettadisiena Wednesday, April 21, 2021 12:35:00 PM CEST | info English text... [en] [other]

Trigger words: [HepatitisC] epatite C[1];

Entities: Massimo Galli[1]; Fabio Landazabal[1];

Other categories: Antiviral; Coronavirus Infection;

È la sede Gsk di Parma a sperimentare sull’anticorpo Vir-7831, mentre proseguono gli studi di Msd, Atea Pharmaceuticals e Pfizer per i farmaci anti-Covid. La gara della ricerca per arrivare ad ottenere una pillola da prendere non appena venuti a conoscenza della propria positività al Covid-19.......

Covid, three new antiviral drugs in arrival while continues the study on...

Parma cfb is the place to test the antibody Vir - 7831, whereas they pursue their studies of Msd, atheist and Pfizer Pharmaceuticals anti-covid medicines. The race of research to gain a pill to be taken once known for its positive Covid - 19....

Gilead: Riva VP dell’oncologia. Sarà il regista del lancio della terapia CAR-T External link

Source country dailyhealthindustry Wednesday, April 21, 2021 11:58:00 AM CEST | info English text... [en] [other]

Trigger words: [HepatitisC] epatite C[1];

Entities: Alessandro Riva[1]; John Milligan[1];

Other categories:

Alessandro Riva è stato nominato vice presidente esecutivo dell’unità oncologica di Gilead. Un ruolo chiave, dal momento che Riva si occuperà anche di terapie cellulari, in particolare di CAR-T, acquisita con l’operazione Kite Pharma, finalizzata qualche settimana fa e costata all’azienda biotech americana 11,9 miliardi di dollari....

Gilead: Riva pv of oncology. Will be the director of the launch of the therapy CAR - t

Alessandro Riva was appointed executive vice president of cancer unit of Gilead. A key role, given that the bank will also tackle cell therapy, especially CAR - T, acquired during the operation Kite Pharma, a few weeks ago and cost the us biotech firm 11.9 billion dollars.

More articles...

Tools

Load latest edition

Wednesday, April 21, 2021

1:36:00 PM CEST

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface: